Congestive Heart Failure

Intensive glucose management can help adults with type 1 diabetes avoid an initial or subsequent cardiovascular disease or major adverse cardiovascular disease event, according to findings published in Diabetes Care.

There is now plentiful evidence that medical therapy benefits patients with peripheral artery disease, which is reflected in guidelines but not followed nearly enough, a speaker stated at the International Symposium on Endovascular Therapy.

News that the FDA is investigating metformin products to determine if potentially carcinogenic agents are present was one of the week’s top stories in endocrinology.

Among adults with type 2 diabetes, the risks for congestive heart failure and all-cause mortality rise with increases in BMI and waist circumference, but there may be a need to reevaluate what constitutes obesity using these metrics, according to findings published in the Journal of Diabetes and its Complications.

Preservation of residual kidney function reduces morbidity, improves survival and offers other benefits to patients with ESKD. However, more study is needed to understand the mechanisms of residual kidney function along with methods and treatments that can successfully extend preservation, according to a recently published study.

A novel therapeutic treatment using a common cold virus could be effective in patients with nonmuscle-invasive bladder cancer, and breast cancer history was associated with an increased risk for congestive heart failure later in life.

Young survivors of breast cancer face higher risk for late congestive heart failure than their counterparts without cancer, according to study results published in Cancer.